Watchlist Price Alert

Relay Therapeutics Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

3.08

-0.19 (-5.81%)

At close: Jun 17, 2025, 3:17 PM

Relay Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-337.71M	-341.97M	-290.51M	-363.87M	-52.41M	-75.31M	-48.78M
Depreciation & Amortization	-6.85M	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M
Stock-Based Compensation	94.14M	86.03M	56.14M	48.45M	31.96M	4.46M	2.89M
Other Working Capital	4.35M	-35.28M	9.16M	277K	571K	1.31M	-1.63M
Other Non-Cash Items	1.31M	-17.18M	-10.49M	137.69M	-416K	-2.44M	9K
Deferred Income Tax	n/a	n/a	n/a	2.05M	n/a	n/a	n/a
Change in Working Capital	n/a	-32.46M	11.25M	97.34M	-85.17M	4.31M	-400K
Operating Cash Flow	-249.11M	-300.32M	-229.49M	-74.41M	-102.49M	-66.13M	-44.13M
Capital Expenditures	-2.02M	-4.13M	-9.06M	-3.47M	-1.93M	-8M	-1.69M
Cash Acquisitions	n/a	n/a	179.68M	-25.3M	-83.6M	20K	7K
Purchase of Investments	-650.63M	-385.54M	-535.42M	-980.66M	-266.45M	-553.52M	n/a
Sales Maturities Of Investments	611.46M	647.3M	355.74M	529.92M	350.06M	242.47M	n/a
Other Investing Acitivies	101K	n/a	-179.68M	-450.74M	83.6M	-311.02M	7K
Investing Cash Flow	-41.08M	257.63M	-188.75M	-479.51M	81.67M	-319.02M	-1.68M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	1.48M	n/a	n/a	n/a	n/a	n/a	-82K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.26M	4.47M	5.17M	5.88M	1.22M	613K	717K
Financial Cash Flow	270.15M	34.75M	289.91M	388.09M	426.51M	5.61M	394.97M
Net Cash Flow	-20.04M	-7.93M	-128.32M	-165.83M	405.69M	-379.55M	349.16M
Free Cash Flow	-251.13M	-304.44M	-238.55M	-77.88M	-104.42M	-74.14M	-45.82M